Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.

晚期非小细胞肺癌的治疗 ： 2019 年 AIOM （ 意大利医学肿瘤协会 ） 临床实践指南。

• 影响指数: 6.625
• 发表时间: Feb 2020
• 来源期刊: Crit Rev Oncol Hematol
• DOI: 10.1016/j.critrevonc.2019.102858
• PMID: 31918343
• 文章类型: Journal Article
• 中科院分区: Q2
• 方向: 医学
• 作者列表: Passiglia F,Pilotto S,Facchinetti F,Bertolaccini L,Del Re M,Ferrara R,Franchina T,Malapelle U,Menis J,Passaro A,Ramella S,Rossi G,Trisolini R,Novello S

关键词: Clinical practice guidelines; Metastatic disease; Non-small cell lung cancer; Recommendations

Mesh: Humans; Antineoplastic Agents / therapeutic use; Carcinoma, Non-Small-Cell Lung / drug therapy pathology; Italy; Lung Neoplasms / drug therapy pathology; Medical Oncology / standards; Societies, Medical

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.

摘要

意大利医学肿瘤协会（AIOM）制定了治疗晚期非小细胞肺癌（NSCLC）患者的临床实践指南。在当前的论文中，胸部恶性肿瘤领域的AIOM专家小组讨论了可用的科学证据，最终目的是提供临床建议摘要，这可以指导医生目前的实践。